Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. annual/quarterly total liabilities history from 2020 to 2022. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cullinan Therapeutics, Inc. total liabilities for the quarter ending December 31, 2022 were 26.1M, a 120.88% increase year-over-year.
- Cullinan Therapeutics, Inc. total liabilities for 2022 were 26.1M, a 120.88% increase from 2021.
- Cullinan Therapeutics, Inc. total liabilities for 2021 were 11.8M, a 17.94% decrease from 2020.
- Cullinan Therapeutics, Inc. total liabilities for 2020 were 14.4M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cullinan Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2022 | $26 |
| 2021 | $12 |
| 2020 | $14 |
| Cullinan Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2022-12-31 | $26 |
| 2021-12-31 | $12 |
| 2020-12-31 | $14 |
Cullinan Therapeutics, Inc. Total Liabilities — FAQ
Cullinan Therapeutics, Inc. (CGEM) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGEM's total liabilities history?
The chart and table above show Cullinan Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.